Apixaban versus enoxaparin to prevent venous thromboembolism in post-operative patients with gynecologic cancers at an urban academic medical center
Objective: A recent clinical trial demonstrated that the use of apixaban was safe and equal to enoxaparin (LMWH) in post-operative gynecologic oncology patients. This study aimed to determine if these findings are applicable in a diverse patient population at a single site urban academic medical cen...
Saved in:
Main Authors: | Victoria Diamond (Author), Katherine Gerber (Author), Geno Merli (Author), Rebecca Mercier (Author), Aaron Shafer (Author), Norman Rosenblum (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CURRENT TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS WITH ANTICOAGULANTS: APIXABAN
by: I. S. Yavelov
Published: (2015) -
Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism
by: Aliya Abdulla, et al.
Published: (2023) -
Efficacy and safety of venous thromboembolism prophylaxis with apixaban in major orthopedic surgery
by: Werth S, et al.
Published: (2012) -
Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events
by: O. V. Shatalova
Published: (2015) -
Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events
by: O. V. Shatalova
Published: (2015)